• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Recurrent Respiratory Papillomatosis

Recurrent Respiratory Papillomatosis - 14 Studies Found

Completed : Avelumab for People With Recurrent Respiratory Papillomatosis
:
  • Recurrent Respiratory Papillomatosis
  • Juve
    : 2016-08-06
    : Drug: Avelumab Avelumab 10 mg/kg IV every 2 weeks for up to 6 doses.
Completed : Study of Anti-PD-1 Therapy for HPV-associated Recurrent Respiratory Papilloma Patients With Laryngeal, Tracheal and/or Pulmonary Involvement
: Recurrent Respiratory Papillomatosis
: 2015-12-10
: Drug: Pembrolizumab 200 mg will be administered as a 30 minute IV infusion every 3 weeks on day 1 of eac
Active, not recruiting : Effect of Vaccination in Patients With Recurrent Respiratory Papillomatosis
: Squamous Papilloma of the Larynx
: 2011-06-16
: Biological: Silgard vaccination with tetravalent antiviral vaccine
Withdrawn : Optical Coherence Tomography of the Airway for Lung Cancer or Lung Disease
:
  • Lung Cancer
  • Malignant Mesothelioma
  • Metastatic Cancer

  • : 2008-08-12
    :
    • Procedure: bronchoscopic and lung imaging studies

<<< Previous
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.